PDCD1 and neoplasm: Many strategies combine to alter tumors’ metabolic landscape to enhance tumor immunotherapy’s efficacy; it has been reported that in tumors with low glucose and high glycolysis metabolism, such as tumors with high MYC gene expression and liver metastases, Tregs cells actively take up lactate, resulting in increased expression of PD-1 (Figure 4).